• Visit our COVID-19 website for information about UWM’s response to the pandemic.

About the MIDD

The Milwaukee Institute for Drug Discovery (MIDD) was established to advance research and later-stage development of new drugs from research at the UW-Milwaukee and collaborating institutions. The Institute will focus on several areas of research strength at UWM; with initiatives in neuroscience, cancer, and infectious diseases. Because of the cross-functional nature of drug discovery and development, the MIDD is focused on collaborations among UWM departments, regional and national academic centers, and medical product companies.

Key Elements of the MIDD Mission:

  • Support exploratory research in focus therapeutic areas
  • Conduct pre-clinical and clinical studies leading to Proof-of-Concept
  • Provide project management, regulatory, CM&C, clinical design, and logistical expertise for development projects
  • Form research and product development collaborations
  • Work closely with the UWM Research Foundation on patenting and licensing
  • Enhance educational opportunities through curriculum and fellowship programs
  • Develop linkages to the greater UWM community and promote regional economic development